Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
27.70
+2.21 (8.67%)
At close: Dec 5, 2025, 4:00 PM EST
27.60
-0.10 (-0.36%)
After-hours: Dec 5, 2025, 7:59 PM EST
Moderna Stock Forecast
Stock Price Forecast
The 11 analysts that cover Moderna stock have a consensus rating of "Hold" and an average price target of $33.91, which forecasts a 22.42% increase in the stock price over the next year. The lowest target is $18 and the highest is $63.
Price Target: $33.91 (+22.42%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Moderna stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 13 | 12 | 12 | 8 | 8 | 8 |
| Sell | 3 | 4 | 4 | 4 | 3 | 3 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 19 | 19 | 15 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $69 → $63 | Buy | Reiterates | $69 → $63 | +127.44% | Nov 21, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $28 → $25 | Hold | Maintains | $28 → $25 | -9.75% | Nov 21, 2025 |
| Leerink Partners | Leerink Partners | Sell Maintains $15 → $18 | Sell | Maintains | $15 → $18 | -35.02% | Nov 21, 2025 |
| Barclays | Barclays | Hold Maintains $31 → $25 | Hold | Maintains | $31 → $25 | -9.75% | Nov 7, 2025 |
| UBS | UBS | Strong Buy Maintains $70 → $40 | Strong Buy | Maintains | $70 → $40 | +44.40% | Oct 23, 2025 |
Financial Forecast
Revenue This Year
1.94B
from 3.24B
Decreased by -40.17%
Revenue Next Year
1.95B
from 1.94B
Increased by 0.77%
EPS This Year
-8.31
from -9.28
EPS Next Year
-7.23
from -8.31
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2.3B | 2.5B | ||||
| Avg | 1.9B | 2.0B | ||||
| Low | 1.7B | 1.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -30.2% | 27.0% | ||||
| Avg | -40.2% | 0.8% | ||||
| Low | -47.5% | -31.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -7.84 | -5.53 | ||||
| Avg | -8.31 | -7.23 | ||||
| Low | -9.39 | -8.21 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.